Multimodal treatment of adult attention-deficit hyperactivity disorder;Multimodale therapie der aufmerksamkeitsdefizit-/ hyperaktivitätsstörung im erwachsenenalter

Nervenarzt

Volumn 79, Issue 7, 2008, Pages 801-808

  Jacob, C P ^a   Philipsen, A ^b   Ebert, D ^b   Deckert, J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adult attention deficit hyperactivity disorder; Atomoxetine; Combination therapy; Methylphenidate; Psychotherapy

Indexed keywords

ATOMOXETINE; METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; COMORBIDITY; HUMAN; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SELF HELP; ADAPTIVE BEHAVIOR; ADULT; DELAYED RELEASE FORMULATION; DRUG CONTRAINDICATION; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT;

ADAPTATION, PSYCHOLOGICAL; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; HUMANS; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PSYCHOTHERAPY; SELF-HELP GROUPS;

EID: 46649114122     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-008-2510-6     Document Type: Review

References (27)

1. The MTA Cooperative Group (1999) A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 56: 1073-1086
2. Abikoff H, Hechtman L, Klein RG et al. (2004) Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 43: 820-829
3. Adler LA, Spencer TJ, Milton DR et al. (2005) Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/ hyperactivity disorder: an interim analysis. J Clin Psychiatry 66: 294-299
4. Advokat C (2007) Update on amphetamine neurotoxicity and its relevance to the treatment of ADHD. J Atten Disord 11: 8-16
5. Biederman J, Spencer TJ, Wilens TE et al. (2005) Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. CNS Spectr 10: 16-25
6. Bramham J, Young S, Bickerdike A et al. (2008) Evaluation of group cognitive behavioral therapy in adults with ADHD. J Atten Disord (in press)
7. Ebert D, Krause J, Roth-Sackenheim C (2003) ADHD in adulthood-guidelines based on expert consensus with DGPPN support. Nervenarzt 74: 939-946
8. Faraone SV, Spencer T, Aleardi M et al. (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24: 24-29
9. Hesslinger B, Philipsen A, Richer H (2002) Psychotherapie der ADHS im Erwachsenenalter - ein Arbeitsbuch. Hogrefe, Göttingen Bern Toronto Seattle Oxford Prag
10. Hesslinger B, Tebartz van Elst L, Nyberg E et al. (2002) Psychotherapy of attention deficit hyperactivity disorder in adults - a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 252: 177-184
11. Jacob C, Romanos J, Dempfle A et al. (2007) Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci 257: 309-317
12. Jacob C, Lesch KP (2006) The Wuerzburg Research Initiative on Adult Attention-Deficit/Hyperactivity Disorder (WURIN-AADHD): Multi-layered evaluation of long-term course. Eur Arch Psychiatry Clin Neurosci [Suppl 1] 256: i12-i20
13. Krause J, la Fougere C, Krause KH et al. (2005) Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci 25: 428-431
14. Kurscheidt JC, Peiler P, Behnken A et al. (2008) Acute effects of methylphenidate on neuropsychological parameters in adults with ADHD: possible relevance for therapy. J Neural Transm 115: 357-362
15. McCann UD, Kuwabara H, Kumar A et al. (2008) Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse 62: 91-100
16. Michelson D, Adler L, Spencer T et al. (2003) Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 53: 112-120
17. Philipsen A, Limberger MF, Lieb K et al. (2008) Attention deficit/ hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry 192: 118-123
18. Philipsen A, Richter H, Peters J et al. (2007) Structured group psychotherapy in adults with attention deficit hyperactivity disorder - Results of an open Group Multicentre Study. J Nerv Ment Dis 195: 1013-1019
19. Safren SA, Otto MW, Sprich S et al. (2005) Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther 43: 831-842
20. Spencer T, Biederman J, Wilens T et al. (2005) A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 456-463
21. Stevenson CS, Whitmont S, Bornholt L et al. (2002) A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 36: 610-616
22. Weisler RH, Biederman J, Spencer TJ et al. (2006) Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 11: 625-639
23. Wiggins D, Singh K (1999) Effects of a brief group intervention for adults with attention deficit/hyperactivity disorder. J Ment Health Counseling 21: 82-92
24. Wilens TE, Biederman J, Mick E, Spencer TJ (1995) A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis 183: 48-50
25. Wilens TE, Biederman J, Prince J et al. (1996) Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153: 1147-1153
26. Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111: 179-185
27. Wilens TE, Haight BR, Horrigan JP et al. (2005) Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry 57: 793-801